28 results
8-K
EX-10.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
) be indemnified by the Company for acting as a Placement Agent hereunder pursuant to the indemnification provisions set forth in the engagement letters
8-K
EX-99.1
CRNX
Crinetics Pharmaceuticals Inc
8 Jan 24
Regulation FD Disclosure
8:03am
with prescribers, market research, payer engagement, and distribution channels. In some cases, you can identify forward-looking statements by terms … Payer Engagement Finalized third party logistics vendor contract Medicaid Medicare Part B Negotiating specialty pharmacy network contracts 9.8
8-K
EX-3.1
CRNX
Crinetics Pharmaceuticals Inc
12 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:35pm
or engagement or to pledge its credit or to render it liable for any purpose or for any amount.
7.2 STOCK CERTIFICATES; PARTLY PAID SHARES
8-K
EX-99.2
qh7bo
30 Mar 22
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
EX-99.1
cdnz 620wun81x
3 Sep 20
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
7:35am
8-K
EX-99.1
wldi43yftbmnhzary06y
13 Nov 18
Crinetics Pharmaceuticals Reports Third Quarter 2018
4:06pm
8-K
EX-3.2
5tq7n6h2j
20 Jul 18
Amendments to Articles of Incorporation or Bylaws
4:05pm
S-1/A
EX-10.8
k4w dwvm8qmi3nszd94j
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
EX-3.4
yeje2f
9 Jul 18
IPO registration (amended)
6:10am
S-1
EX-10.2
njbt3bchk9xo75lrcb
22 Jun 18
IPO registration
4:07pm
S-1
EX-10.6
qpxfn
22 Jun 18
IPO registration
4:07pm